# Contact Topical Peptides — Editorial Desk

> Reach the Topical Peptides editorial desk regarding citations, corrections, or research-related correspondence about GHK-Cu, semaglutide, and thymosin alpha-1.

Correspondence on citations, corrections, and research-related questions about GHK-Cu, semaglutide, and thymosin alpha-1.

## Editorial correspondence

Topical Peptides welcomes correspondence on the research record: a citation quoted inaccurately, a newly published trial on GHK-Cu, semaglutide, or thymosin alpha-1, or a regulatory update that changes an approval status described on this site. This class of correction is the most useful message this desk receives, and each is read carefully.

The most actionable messages specify the page in question, the exact passage being corrected or challenged, and a supporting reference — a DOI or PubMed identifier wherever possible — so the proposed change can be checked against its source before anything is updated.

**Editorial mailbox:** editors@topicalpeptides.com

## What this desk cannot do

Topical Peptides is a literature digest, not a clinical service or product seller, so it cannot advise on or recommend human use of any peptide discussed here, suggest a dose or schedule for any individual, evaluate whether a cited finding applies to a specific person's situation, or help locate any compound from any supplier. It also cannot provide guidance on obtaining prescription medicines outside of a licensed prescriber-patient relationship.

Semaglutide is a prescription medicine. Thymosin alpha-1 is approved abroad but not in the United States, where it remains investigational. GHK-Cu's topical, cosmetic form is legal and widely available; other routes are unapproved and unstudied in humans. Readers seeking medical guidance should consult a licensed clinician in their jurisdiction. Responses to editorial correspondence are not guaranteed and may be delayed.

---

A literary field guide to how research peptides reach the body — built on citations, not prescriptions, and never a recommended dose.